id	sid	tid	token	lemma	pos
cord-321976-ao3bg8xi	1	1	key	key	NN
cord-321976-ao3bg8xi	1	2	:	:	:
cord-321976-ao3bg8xi	2	1	cord-321976-ao3bg8xi	cord-321976-ao3bg8xi	NNP
cord-321976-ao3bg8xi	2	2	authors	author	NNS
cord-321976-ao3bg8xi	2	3	:	:	:
cord-321976-ao3bg8xi	2	4	Robinson	Robinson	NNP
cord-321976-ao3bg8xi	2	5	,	,	,
cord-321976-ao3bg8xi	2	6	Philip	Philip	NNP
cord-321976-ao3bg8xi	2	7	C	C	NNP
cord-321976-ao3bg8xi	2	8	;	;	:
cord-321976-ao3bg8xi	2	9	Bursle	Bursle	NNP
cord-321976-ao3bg8xi	2	10	,	,	,
cord-321976-ao3bg8xi	2	11	Evan	Evan	NNP
cord-321976-ao3bg8xi	2	12	C	C	NNP
cord-321976-ao3bg8xi	2	13	title	title	NN
cord-321976-ao3bg8xi	2	14	:	:	:
cord-321976-ao3bg8xi	2	15	Management	management	NN
cord-321976-ao3bg8xi	2	16	of	of	IN
cord-321976-ao3bg8xi	2	17	autoimmune	autoimmune	JJ
cord-321976-ao3bg8xi	2	18	disease	disease	NN
cord-321976-ao3bg8xi	2	19	during	during	IN
cord-321976-ao3bg8xi	2	20	the	the	DT
cord-321976-ao3bg8xi	2	21	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	2	22	pandemic	pandemic	NN
cord-321976-ao3bg8xi	2	23	date	date	NN
cord-321976-ao3bg8xi	2	24	:	:	:
cord-321976-ao3bg8xi	2	25	2020	2020	CD
cord-321976-ao3bg8xi	2	26	-	-	HYPH
cord-321976-ao3bg8xi	2	27	08	08	CD
cord-321976-ao3bg8xi	2	28	-	-	SYM
cord-321976-ao3bg8xi	2	29	18	18	CD
cord-321976-ao3bg8xi	2	30	journal	journal	NN
cord-321976-ao3bg8xi	2	31	:	:	:
cord-321976-ao3bg8xi	3	1	Aust	Aust	NNP
cord-321976-ao3bg8xi	3	2	Prescr	Prescr	NNP
cord-321976-ao3bg8xi	3	3	DOI	DOI	NNP
cord-321976-ao3bg8xi	3	4	:	:	:
cord-321976-ao3bg8xi	4	1	10.18773/	10.18773/	CD
cord-321976-ao3bg8xi	5	1	austprescr.2020.058	austprescr.2020.058	IN
cord-321976-ao3bg8xi	5	2	sha	sha	NNP
cord-321976-ao3bg8xi	5	3	:	:	:
cord-321976-ao3bg8xi	5	4	f4faa41be9c2aa6fcce8d58002b0053f928c08f5	f4faa41be9c2aa6fcce8d58002b0053f928c08f5	CD
cord-321976-ao3bg8xi	5	5	doc_id	doc_id	CD
cord-321976-ao3bg8xi	5	6	:	:	:
cord-321976-ao3bg8xi	5	7	321976	321976	CD
cord-321976-ao3bg8xi	5	8	cord_uid	cord_uid	NNS
cord-321976-ao3bg8xi	5	9	:	:	:
cord-321976-ao3bg8xi	6	1	ao3bg8xi	ao3bg8xi	NNP
cord-321976-ao3bg8xi	6	2	nan	nan	NNP
cord-321976-ao3bg8xi	6	3	Modifiable	modifiable	JJ
cord-321976-ao3bg8xi	6	4	risk	risk	NN
cord-321976-ao3bg8xi	6	5	factors	factor	NNS
cord-321976-ao3bg8xi	6	6	for	for	IN
cord-321976-ao3bg8xi	6	7	adverse	adverse	JJ
cord-321976-ao3bg8xi	6	8	outcomes	outcome	NNS
cord-321976-ao3bg8xi	6	9	in	in	IN
cord-321976-ao3bg8xi	6	10	COVID-19	covid-19	DT
cord-321976-ao3bg8xi	6	11	include	include	VBP
cord-321976-ao3bg8xi	6	12	drugs	drug	NNS
cord-321976-ao3bg8xi	6	13	.	.	.
cord-321976-ao3bg8xi	7	1	So	so	RB
cord-321976-ao3bg8xi	7	2	far	far	RB
cord-321976-ao3bg8xi	7	3	there	there	EX
cord-321976-ao3bg8xi	7	4	has	have	VBZ
cord-321976-ao3bg8xi	7	5	not	not	RB
cord-321976-ao3bg8xi	7	6	been	be	VBN
cord-321976-ao3bg8xi	7	7	any	any	DT
cord-321976-ao3bg8xi	7	8	increase	increase	NN
cord-321976-ao3bg8xi	7	9	in	in	IN
cord-321976-ao3bg8xi	7	10	the	the	DT
cord-321976-ao3bg8xi	7	11	risk	risk	NN
cord-321976-ao3bg8xi	7	12	of	of	IN
cord-321976-ao3bg8xi	7	13	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	7	14	for	for	IN
cord-321976-ao3bg8xi	7	15	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	7	16	in	in	IN
cord-321976-ao3bg8xi	7	17	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	7	18	disease	disease	NN
cord-321976-ao3bg8xi	7	19	patients	patient	NNS
cord-321976-ao3bg8xi	7	20	taking	take	VBG
cord-321976-ao3bg8xi	7	21	disease	disease	NN
cord-321976-ao3bg8xi	7	22	-	-	HYPH
cord-321976-ao3bg8xi	7	23	modifying	modify	VBG
cord-321976-ao3bg8xi	7	24	antirheumatic	antirheumatic	JJ
cord-321976-ao3bg8xi	7	25	drugs	drug	NNS
cord-321976-ao3bg8xi	7	26	alone	alone	JJ
cord-321976-ao3bg8xi	7	27	(	(	-LRB-
cord-321976-ao3bg8xi	7	28	e.g.	e.g.	RB
cord-321976-ao3bg8xi	7	29	methotrexate	methotrexate	NNP
cord-321976-ao3bg8xi	7	30	)	)	-RRB-
cord-321976-ao3bg8xi	7	31	or	or	CC
cord-321976-ao3bg8xi	7	32	in	in	IN
cord-321976-ao3bg8xi	7	33	combination	combination	NN
cord-321976-ao3bg8xi	7	34	with	with	IN
cord-321976-ao3bg8xi	7	35	biologics	biologic	NNS
cord-321976-ao3bg8xi	7	36	or	or	CC
cord-321976-ao3bg8xi	7	37	Janus	Janus	NNP
cord-321976-ao3bg8xi	7	38	kinase	kinase	NN
cord-321976-ao3bg8xi	7	39	inhibitors	inhibitor	NNS
cord-321976-ao3bg8xi	7	40	,	,	,
cord-321976-ao3bg8xi	7	41	compared	compare	VBN
cord-321976-ao3bg8xi	7	42	to	to	IN
cord-321976-ao3bg8xi	7	43	patients	patient	NNS
cord-321976-ao3bg8xi	7	44	who	who	WP
cord-321976-ao3bg8xi	7	45	were	be	VBD
cord-321976-ao3bg8xi	7	46	not	not	RB
cord-321976-ao3bg8xi	7	47	taking	take	VBG
cord-321976-ao3bg8xi	7	48	these	these	DT
cord-321976-ao3bg8xi	7	49	drugs	drug	NNS
cord-321976-ao3bg8xi	7	50	.	.	.
cord-321976-ao3bg8xi	8	1	1	1	LS
cord-321976-ao3bg8xi	9	1	Similarly	similarly	RB
cord-321976-ao3bg8xi	9	2	,	,	,
cord-321976-ao3bg8xi	9	3	non	non	JJ
cord-321976-ao3bg8xi	9	4	-	-	JJ
cord-321976-ao3bg8xi	9	5	steroidal	steroidal	JJ
cord-321976-ao3bg8xi	9	6	anti	anti	JJ
cord-321976-ao3bg8xi	9	7	-	-	JJ
cord-321976-ao3bg8xi	9	8	inflammatory	inflammatory	JJ
cord-321976-ao3bg8xi	9	9	drugs	drug	NNS
cord-321976-ao3bg8xi	9	10	and	and	CC
cord-321976-ao3bg8xi	9	11	hydroxychloroquine	hydroxychloroquine	NNP
cord-321976-ao3bg8xi	9	12	did	do	VBD
cord-321976-ao3bg8xi	9	13	not	not	RB
cord-321976-ao3bg8xi	9	14	alter	alter	VB
cord-321976-ao3bg8xi	9	15	the	the	DT
cord-321976-ao3bg8xi	9	16	risk	risk	NN
cord-321976-ao3bg8xi	9	17	of	of	IN
cord-321976-ao3bg8xi	9	18	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	9	19	with	with	IN
cord-321976-ao3bg8xi	9	20	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	9	21	.	.	.
cord-321976-ao3bg8xi	10	1	Treatment	treatment	NN
cord-321976-ao3bg8xi	10	2	with	with	IN
cord-321976-ao3bg8xi	10	3	tumour	tumour	NN
cord-321976-ao3bg8xi	10	4	necrosis	necrosis	NN
cord-321976-ao3bg8xi	10	5	factor	factor	NN
cord-321976-ao3bg8xi	10	6	inhibitors	inhibitor	NNS
cord-321976-ao3bg8xi	10	7	reduced	reduce	VBD
cord-321976-ao3bg8xi	10	8	the	the	DT
cord-321976-ao3bg8xi	10	9	odds	odd	NNS
cord-321976-ao3bg8xi	10	10	of	of	IN
cord-321976-ao3bg8xi	10	11	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	10	12	,	,	,
cord-321976-ao3bg8xi	10	13	with	with	IN
cord-321976-ao3bg8xi	10	14	an	an	DT
cord-321976-ao3bg8xi	10	15	adjusted	adjust	VBN
cord-321976-ao3bg8xi	10	16	odds	odd	NNS
cord-321976-ao3bg8xi	10	17	ratio	ratio	NN
cord-321976-ao3bg8xi	10	18	(	(	-LRB-
cord-321976-ao3bg8xi	10	19	aOR	aor	NN
cord-321976-ao3bg8xi	10	20	)	)	-RRB-
cord-321976-ao3bg8xi	10	21	of	of	IN
cord-321976-ao3bg8xi	10	22	0.4	0.4	CD
cord-321976-ao3bg8xi	10	23	(	(	-LRB-
cord-321976-ao3bg8xi	10	24	95	95	CD
cord-321976-ao3bg8xi	10	25	%	%	NN
cord-321976-ao3bg8xi	10	26	confidence	confidence	NN
cord-321976-ao3bg8xi	10	27	interval	interval	NN
cord-321976-ao3bg8xi	10	28	(	(	-LRB-
cord-321976-ao3bg8xi	10	29	CI	CI	NNP
cord-321976-ao3bg8xi	10	30	)	)	-RRB-
cord-321976-ao3bg8xi	10	31	0.19	0.19	CD
cord-321976-ao3bg8xi	10	32	-	-	SYM
cord-321976-ao3bg8xi	10	33	0.81	0.81	CD
cord-321976-ao3bg8xi	10	34	)	)	-RRB-
cord-321976-ao3bg8xi	10	35	.	.	.
cord-321976-ao3bg8xi	11	1	However	however	RB
cord-321976-ao3bg8xi	11	2	,	,	,
cord-321976-ao3bg8xi	11	3	prednisone	prednisone	NN
cord-321976-ao3bg8xi	11	4	at	at	IN
cord-321976-ao3bg8xi	11	5	a	a	DT
cord-321976-ao3bg8xi	11	6	dose	dose	NN
cord-321976-ao3bg8xi	11	7	of	of	IN
cord-321976-ao3bg8xi	11	8	10	10	CD
cord-321976-ao3bg8xi	11	9	mg	mg	NN
cord-321976-ao3bg8xi	11	10	or	or	CC
cord-321976-ao3bg8xi	11	11	more	more	JJR
cord-321976-ao3bg8xi	11	12	increased	increase	VBD
cord-321976-ao3bg8xi	11	13	the	the	DT
cord-321976-ao3bg8xi	11	14	odds	odd	NNS
cord-321976-ao3bg8xi	11	15	of	of	IN
cord-321976-ao3bg8xi	11	16	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	11	17	-aOR	-aOR	:
cord-321976-ao3bg8xi	11	18	2.05	2.05	CD
cord-321976-ao3bg8xi	12	1	(	(	-LRB-
cord-321976-ao3bg8xi	12	2	95	95	CD
cord-321976-ao3bg8xi	12	3	%	%	NN
cord-321976-ao3bg8xi	12	4	CI	CI	NNP
cord-321976-ao3bg8xi	12	5	1.06	1.06	CD
cord-321976-ao3bg8xi	12	6	-	-	HYPH
cord-321976-ao3bg8xi	12	7	3.96	3.96	CD
cord-321976-ao3bg8xi	12	8	)	)	-RRB-
cord-321976-ao3bg8xi	12	9	.	.	.
cord-321976-ao3bg8xi	13	1	1	1	LS
cord-321976-ao3bg8xi	14	1	Another	another	DT
cord-321976-ao3bg8xi	14	2	study	study	NN
cord-321976-ao3bg8xi	14	3	of	of	IN
cord-321976-ao3bg8xi	14	4	people	people	NNS
cord-321976-ao3bg8xi	14	5	infected	infect	VBN
cord-321976-ao3bg8xi	14	6	with	with	IN
cord-321976-ao3bg8xi	14	7	COVID-19	covid-19	CD
cord-321976-ao3bg8xi	14	8	compared	compare	VBN
cord-321976-ao3bg8xi	14	9	52	52	CD
cord-321976-ao3bg8xi	14	10	patients	patient	NNS
cord-321976-ao3bg8xi	14	11	with	with	IN
cord-321976-ao3bg8xi	14	12	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	14	13	disease	disease	NN
cord-321976-ao3bg8xi	14	14	,	,	,
cord-321976-ao3bg8xi	14	15	including	include	VBG
cord-321976-ao3bg8xi	14	16	39	39	CD
cord-321976-ao3bg8xi	14	17	taking	take	VBG
cord-321976-ao3bg8xi	14	18	immunosuppressants	immunosuppressant	NNS
cord-321976-ao3bg8xi	14	19	,	,	,
cord-321976-ao3bg8xi	14	20	with	with	IN
cord-321976-ao3bg8xi	14	21	104	104	CD
cord-321976-ao3bg8xi	14	22	matched	match	VBN
cord-321976-ao3bg8xi	14	23	COVID-19	covid-19	CD
cord-321976-ao3bg8xi	14	24	positive	positive	JJ
cord-321976-ao3bg8xi	14	25	controls	control	NNS
cord-321976-ao3bg8xi	14	26	.	.	.
cord-321976-ao3bg8xi	15	1	There	there	EX
cord-321976-ao3bg8xi	15	2	was	be	VBD
cord-321976-ao3bg8xi	15	3	no	no	DT
cord-321976-ao3bg8xi	15	4	significant	significant	JJ
cord-321976-ao3bg8xi	15	5	difference	difference	NN
cord-321976-ao3bg8xi	15	6	between	between	IN
cord-321976-ao3bg8xi	15	7	the	the	DT
cord-321976-ao3bg8xi	15	8	groups	group	NNS
cord-321976-ao3bg8xi	15	9	in	in	IN
cord-321976-ao3bg8xi	15	10	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	15	11	,	,	,
cord-321976-ao3bg8xi	15	12	length	length	NN
cord-321976-ao3bg8xi	15	13	of	of	IN
cord-321976-ao3bg8xi	15	14	stay	stay	NN
cord-321976-ao3bg8xi	15	15	in	in	IN
cord-321976-ao3bg8xi	15	16	hospital	hospital	NN
cord-321976-ao3bg8xi	15	17	,	,	,
cord-321976-ao3bg8xi	15	18	oxygen	oxygen	NN
cord-321976-ao3bg8xi	15	19	therapy	therapy	NN
cord-321976-ao3bg8xi	15	20	or	or	CC
cord-321976-ao3bg8xi	15	21	death	death	NN
cord-321976-ao3bg8xi	15	22	.	.	.
cord-321976-ao3bg8xi	16	1	However	however	RB
cord-321976-ao3bg8xi	16	2	,	,	,
cord-321976-ao3bg8xi	16	3	patients	patient	NNS
cord-321976-ao3bg8xi	16	4	with	with	IN
cord-321976-ao3bg8xi	16	5	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	16	6	disease	disease	NN
cord-321976-ao3bg8xi	16	7	were	be	VBD
cord-321976-ao3bg8xi	16	8	more	more	RBR
cord-321976-ao3bg8xi	16	9	likely	likely	JJ
cord-321976-ao3bg8xi	16	10	to	to	TO
cord-321976-ao3bg8xi	16	11	require	require	VB
cord-321976-ao3bg8xi	16	12	intensive	intensive	JJ
cord-321976-ao3bg8xi	16	13	care	care	NN
cord-321976-ao3bg8xi	16	14	or	or	CC
cord-321976-ao3bg8xi	16	15	ventilation	ventilation	NN
cord-321976-ao3bg8xi	16	16	.	.	.
cord-321976-ao3bg8xi	17	1	3	3	LS
cord-321976-ao3bg8xi	18	1	In	in	IN
cord-321976-ao3bg8xi	18	2	a	a	DT
cord-321976-ao3bg8xi	18	3	series	series	NN
cord-321976-ao3bg8xi	18	4	of	of	IN
cord-321976-ao3bg8xi	18	5	525	525	CD
cord-321976-ao3bg8xi	18	6	patients	patient	NNS
cord-321976-ao3bg8xi	18	7	with	with	IN
cord-321976-ao3bg8xi	18	8	inflammatory	inflammatory	JJ
cord-321976-ao3bg8xi	18	9	bowel	bowel	NN
cord-321976-ao3bg8xi	18	10	disease	disease	NN
cord-321976-ao3bg8xi	18	11	,	,	,
cord-321976-ao3bg8xi	18	12	poorer	poor	JJR
cord-321976-ao3bg8xi	18	13	outcomes	outcome	NNS
cord-321976-ao3bg8xi	18	14	with	with	IN
cord-321976-ao3bg8xi	18	15	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	18	16	were	be	VBD
cord-321976-ao3bg8xi	18	17	associated	associate	VBN
cord-321976-ao3bg8xi	18	18	with	with	IN
cord-321976-ao3bg8xi	18	19	increasing	increase	VBG
cord-321976-ao3bg8xi	18	20	age	age	NN
cord-321976-ao3bg8xi	18	21	,	,	,
cord-321976-ao3bg8xi	18	22	comorbidities	comorbiditie	NNS
cord-321976-ao3bg8xi	18	23	and	and	CC
cord-321976-ao3bg8xi	18	24	systemic	systemic	JJ
cord-321976-ao3bg8xi	18	25	glucocorticoids	glucocorticoid	NNS
cord-321976-ao3bg8xi	18	26	.	.	.
cord-321976-ao3bg8xi	19	1	Tumour	tumour	NN
cord-321976-ao3bg8xi	19	2	necrosis	necrosis	NN
cord-321976-ao3bg8xi	19	3	factor	factor	NN
cord-321976-ao3bg8xi	19	4	inhibitors	inhibitor	NNS
cord-321976-ao3bg8xi	19	5	were	be	VBD
cord-321976-ao3bg8xi	19	6	not	not	RB
cord-321976-ao3bg8xi	19	7	associated	associate	VBN
cord-321976-ao3bg8xi	19	8	with	with	IN
cord-321976-ao3bg8xi	19	9	an	an	DT
cord-321976-ao3bg8xi	19	10	increased	increase	VBN
cord-321976-ao3bg8xi	19	11	risk	risk	NN
cord-321976-ao3bg8xi	19	12	of	of	IN
cord-321976-ao3bg8xi	19	13	a	a	DT
cord-321976-ao3bg8xi	19	14	poor	poor	JJ
cord-321976-ao3bg8xi	19	15	outcome	outcome	NN
cord-321976-ao3bg8xi	19	16	.	.	.
cord-321976-ao3bg8xi	20	1	Aminosalicylates	Aminosalicylates	NNP
cord-321976-ao3bg8xi	20	2	,	,	,
cord-321976-ao3bg8xi	20	3	such	such	JJ
cord-321976-ao3bg8xi	20	4	as	as	IN
cord-321976-ao3bg8xi	20	5	sulfasalazine	sulfasalazine	NN
cord-321976-ao3bg8xi	20	6	,	,	,
cord-321976-ao3bg8xi	20	7	were	be	VBD
cord-321976-ao3bg8xi	20	8	associated	associate	VBN
cord-321976-ao3bg8xi	20	9	with	with	IN
cord-321976-ao3bg8xi	20	10	some	some	DT
cord-321976-ao3bg8xi	20	11	composite	composite	JJ
cord-321976-ao3bg8xi	20	12	end	end	NN
cord-321976-ao3bg8xi	20	13	points	point	NNS
cord-321976-ao3bg8xi	20	14	of	of	IN
cord-321976-ao3bg8xi	20	15	poor	poor	JJ
cord-321976-ao3bg8xi	20	16	outcome	outcome	NN
cord-321976-ao3bg8xi	20	17	but	but	CC
cord-321976-ao3bg8xi	20	18	not	not	RB
cord-321976-ao3bg8xi	20	19	others	other	NNS
cord-321976-ao3bg8xi	20	20	,	,	,
cord-321976-ao3bg8xi	20	21	so	so	CC
cord-321976-ao3bg8xi	20	22	caution	caution	NN
cord-321976-ao3bg8xi	20	23	is	be	VBZ
cord-321976-ao3bg8xi	20	24	required	require	VBN
cord-321976-ao3bg8xi	20	25	when	when	WRB
cord-321976-ao3bg8xi	20	26	interpreting	interpret	VBG
cord-321976-ao3bg8xi	20	27	this	this	DT
cord-321976-ao3bg8xi	20	28	result	result	NN
cord-321976-ao3bg8xi	20	29	and	and	CC
cord-321976-ao3bg8xi	20	30	further	further	JJ
cord-321976-ao3bg8xi	20	31	study	study	NN
cord-321976-ao3bg8xi	20	32	is	be	VBZ
cord-321976-ao3bg8xi	20	33	required	require	VBN
cord-321976-ao3bg8xi	20	34	.	.	.
cord-321976-ao3bg8xi	21	1	4	4	LS
cord-321976-ao3bg8xi	22	1	When	when	WRB
cord-321976-ao3bg8xi	22	2	advising	advise	VBG
cord-321976-ao3bg8xi	22	3	patients	patient	NNS
cord-321976-ao3bg8xi	22	4	taking	take	VBG
cord-321976-ao3bg8xi	22	5	immunosuppressive	immunosuppressive	JJ
cord-321976-ao3bg8xi	22	6	drugs	drug	NNS
cord-321976-ao3bg8xi	22	7	during	during	IN
cord-321976-ao3bg8xi	22	8	the	the	DT
cord-321976-ao3bg8xi	22	9	pandemic	pandemic	NN
cord-321976-ao3bg8xi	22	10	,	,	,
cord-321976-ao3bg8xi	22	11	a	a	DT
cord-321976-ao3bg8xi	22	12	comprehensive	comprehensive	JJ
cord-321976-ao3bg8xi	22	13	risk	risk	NN
cord-321976-ao3bg8xi	22	14	assessment	assessment	NN
cord-321976-ao3bg8xi	22	15	should	should	MD
cord-321976-ao3bg8xi	22	16	consider	consider	VB
cord-321976-ao3bg8xi	22	17	the	the	DT
cord-321976-ao3bg8xi	22	18	consequences	consequence	NNS
cord-321976-ao3bg8xi	22	19	of	of	IN
cord-321976-ao3bg8xi	22	20	changing	change	VBG
cord-321976-ao3bg8xi	22	21	treatment	treatment	NN
cord-321976-ao3bg8xi	22	22	.	.	.
cord-321976-ao3bg8xi	23	1	Stopping	stop	VBG
cord-321976-ao3bg8xi	23	2	the	the	DT
cord-321976-ao3bg8xi	23	3	drugs	drug	NNS
cord-321976-ao3bg8xi	23	4	could	could	MD
cord-321976-ao3bg8xi	23	5	cause	cause	VB
cord-321976-ao3bg8xi	23	6	a	a	DT
cord-321976-ao3bg8xi	23	7	flare	flare	NN
cord-321976-ao3bg8xi	23	8	of	of	IN
cord-321976-ao3bg8xi	23	9	the	the	DT
cord-321976-ao3bg8xi	23	10	underlying	underlie	VBG
cord-321976-ao3bg8xi	23	11	disease	disease	NN
cord-321976-ao3bg8xi	23	12	or	or	CC
cord-321976-ao3bg8xi	23	13	other	other	JJ
cord-321976-ao3bg8xi	23	14	disease	disease	NN
cord-321976-ao3bg8xi	23	15	complications	complication	NNS
cord-321976-ao3bg8xi	23	16	.	.	.
cord-321976-ao3bg8xi	24	1	As	as	IN
cord-321976-ao3bg8xi	24	2	with	with	IN
cord-321976-ao3bg8xi	24	3	all	all	DT
cord-321976-ao3bg8xi	24	4	treatment	treatment	NN
cord-321976-ao3bg8xi	24	5	decisions	decision	NNS
cord-321976-ao3bg8xi	24	6	,	,	,
cord-321976-ao3bg8xi	24	7	patients	patient	NNS
cord-321976-ao3bg8xi	24	8	have	have	VBP
cord-321976-ao3bg8xi	24	9	their	-PRON-	PRP$
cord-321976-ao3bg8xi	24	10	own	own	JJ
cord-321976-ao3bg8xi	24	11	values	value	NNS
cord-321976-ao3bg8xi	24	12	and	and	CC
cord-321976-ao3bg8xi	24	13	tolerances	tolerance	NNS
cord-321976-ao3bg8xi	24	14	for	for	IN
cord-321976-ao3bg8xi	24	15	risk	risk	NN
cord-321976-ao3bg8xi	24	16	.	.	.
cord-321976-ao3bg8xi	25	1	Patients	patient	NNS
cord-321976-ao3bg8xi	25	2	are	be	VBP
cord-321976-ao3bg8xi	25	3	often	often	RB
cord-321976-ao3bg8xi	25	4	substantially	substantially	RB
cord-321976-ao3bg8xi	25	5	influenced	influence	VBN
cord-321976-ao3bg8xi	25	6	by	by	IN
cord-321976-ao3bg8xi	25	7	personal	personal	JJ
cord-321976-ao3bg8xi	25	8	,	,	,
cord-321976-ao3bg8xi	25	9	financial	financial	JJ
cord-321976-ao3bg8xi	25	10	and	and	CC
cord-321976-ao3bg8xi	25	11	social	social	JJ
cord-321976-ao3bg8xi	25	12	factors	factor	NNS
cord-321976-ao3bg8xi	25	13	.	.	.
cord-321976-ao3bg8xi	26	1	General	general	JJ
cord-321976-ao3bg8xi	26	2	guidance	guidance	NN
cord-321976-ao3bg8xi	26	3	is	be	VBZ
cord-321976-ao3bg8xi	26	4	often	often	RB
cord-321976-ao3bg8xi	26	5	helpful	helpful	JJ
cord-321976-ao3bg8xi	26	6	,	,	,
cord-321976-ao3bg8xi	26	7	with	with	IN
cord-321976-ao3bg8xi	26	8	subsequent	subsequent	JJ
cord-321976-ao3bg8xi	26	9	adjustments	adjustment	NNS
cord-321976-ao3bg8xi	26	10	to	to	TO
cord-321976-ao3bg8xi	26	11	suit	suit	VB
cord-321976-ao3bg8xi	26	12	the	the	DT
cord-321976-ao3bg8xi	26	13	patient	patient	NN
cord-321976-ao3bg8xi	26	14	's	's	POS
cord-321976-ao3bg8xi	26	15	own	own	JJ
cord-321976-ao3bg8xi	26	16	situation	situation	NN
cord-321976-ao3bg8xi	26	17	.	.	.
cord-321976-ao3bg8xi	27	1	The	the	DT
cord-321976-ao3bg8xi	27	2	American	American	NNP
cord-321976-ao3bg8xi	27	3	College	College	NNP
cord-321976-ao3bg8xi	27	4	of	of	IN
cord-321976-ao3bg8xi	27	5	Rheumatology	Rheumatology	NNP
cord-321976-ao3bg8xi	27	6	(	(	-LRB-
cord-321976-ao3bg8xi	27	7	ACR	ACR	NNP
cord-321976-ao3bg8xi	27	8	)	)	-RRB-
cord-321976-ao3bg8xi	27	9	and	and	CC
cord-321976-ao3bg8xi	27	10	the	the	DT
cord-321976-ao3bg8xi	27	11	European	European	NNP
cord-321976-ao3bg8xi	27	12	League	League	NNP
cord-321976-ao3bg8xi	27	13	Against	Against	NNP
cord-321976-ao3bg8xi	27	14	Rheumatism	Rheumatism	NNP
cord-321976-ao3bg8xi	27	15	recommend	recommend	VBP
cord-321976-ao3bg8xi	27	16	that	that	IN
cord-321976-ao3bg8xi	27	17	in	in	IN
cord-321976-ao3bg8xi	27	18	the	the	DT
cord-321976-ao3bg8xi	27	19	absence	absence	NN
cord-321976-ao3bg8xi	27	20	Immunosuppression	Immunosuppression	NNP
cord-321976-ao3bg8xi	27	21	is	be	VBZ
cord-321976-ao3bg8xi	27	22	an	an	DT
cord-321976-ao3bg8xi	27	23	important	important	JJ
cord-321976-ao3bg8xi	27	24	part	part	NN
cord-321976-ao3bg8xi	27	25	of	of	IN
cord-321976-ao3bg8xi	27	26	the	the	DT
cord-321976-ao3bg8xi	27	27	management	management	NN
cord-321976-ao3bg8xi	27	28	of	of	IN
cord-321976-ao3bg8xi	27	29	autoimmune	autoimmune	JJ
cord-321976-ao3bg8xi	27	30	diseases	disease	NNS
cord-321976-ao3bg8xi	27	31	.	.	.
cord-321976-ao3bg8xi	28	1	As	as	IN
cord-321976-ao3bg8xi	28	2	with	with	IN
cord-321976-ao3bg8xi	28	3	all	all	DT
cord-321976-ao3bg8xi	28	4	treatments	treatment	NNS
cord-321976-ao3bg8xi	28	5	,	,	,
cord-321976-ao3bg8xi	28	6	immunosuppressants	immunosuppressant	NNS
cord-321976-ao3bg8xi	28	7	are	be	VBP
cord-321976-ao3bg8xi	28	8	prescribed	prescribe	VBN
cord-321976-ao3bg8xi	28	9	based	base	VBN
cord-321976-ao3bg8xi	28	10	on	on	IN
cord-321976-ao3bg8xi	28	11	a	a	DT
cord-321976-ao3bg8xi	28	12	balance	balance	NN
cord-321976-ao3bg8xi	28	13	of	of	IN
cord-321976-ao3bg8xi	28	14	harm	harm	NN
cord-321976-ao3bg8xi	28	15	and	and	CC
cord-321976-ao3bg8xi	28	16	benefit	benefit	NN
cord-321976-ao3bg8xi	28	17	.	.	.
cord-321976-ao3bg8xi	29	1	This	this	DT
cord-321976-ao3bg8xi	29	2	balance	balance	NN
cord-321976-ao3bg8xi	29	3	needs	need	VBZ
cord-321976-ao3bg8xi	29	4	to	to	TO
cord-321976-ao3bg8xi	29	5	be	be	VB
cord-321976-ao3bg8xi	29	6	re	re	VBN
cord-321976-ao3bg8xi	29	7	-	-	VBN
cord-321976-ao3bg8xi	29	8	evaluated	evaluate	VBN
cord-321976-ao3bg8xi	29	9	in	in	IN
cord-321976-ao3bg8xi	29	10	the	the	DT
cord-321976-ao3bg8xi	29	11	context	context	NN
cord-321976-ao3bg8xi	29	12	of	of	IN
cord-321976-ao3bg8xi	29	13	the	the	DT
cord-321976-ao3bg8xi	29	14	pandemic	pandemic	NN
cord-321976-ao3bg8xi	29	15	caused	cause	VBN
cord-321976-ao3bg8xi	29	16	by	by	IN
cord-321976-ao3bg8xi	29	17	severe	severe	JJ
cord-321976-ao3bg8xi	29	18	acute	acute	JJ
cord-321976-ao3bg8xi	29	19	respiratory	respiratory	JJ
cord-321976-ao3bg8xi	29	20	syndrome	syndrome	NN
cord-321976-ao3bg8xi	29	21	coronavirus-2	coronavirus-2	NN
cord-321976-ao3bg8xi	30	1	(	(	-LRB-
cord-321976-ao3bg8xi	30	2	SARS	SARS	NNP
cord-321976-ao3bg8xi	30	3	-	-	HYPH
cord-321976-ao3bg8xi	30	4	CoV-2	CoV-2	NNP
cord-321976-ao3bg8xi	30	5	)	)	-RRB-
cord-321976-ao3bg8xi	30	6	.	.	.
cord-321976-ao3bg8xi	31	1	However	however	RB
cord-321976-ao3bg8xi	31	2	,	,	,
cord-321976-ao3bg8xi	31	3	as	as	IN
cord-321976-ao3bg8xi	31	4	the	the	DT
cord-321976-ao3bg8xi	31	5	pandemic	pandemic	NN
cord-321976-ao3bg8xi	31	6	is	be	VBZ
cord-321976-ao3bg8xi	31	7	rapidly	rapidly	RB
cord-321976-ao3bg8xi	31	8	evolving	evolve	VBG
cord-321976-ao3bg8xi	31	9	,	,	,
cord-321976-ao3bg8xi	31	10	this	this	DT
cord-321976-ao3bg8xi	31	11	evaluation	evaluation	NN
cord-321976-ao3bg8xi	31	12	must	must	MD
cord-321976-ao3bg8xi	31	13	be	be	VB
cord-321976-ao3bg8xi	31	14	made	make	VBN
cord-321976-ao3bg8xi	31	15	with	with	IN
cord-321976-ao3bg8xi	31	16	constantly	constantly	RB
cord-321976-ao3bg8xi	31	17	changing	change	VBG
cord-321976-ao3bg8xi	31	18	,	,	,
cord-321976-ao3bg8xi	31	19	imperfect	imperfect	JJ
cord-321976-ao3bg8xi	31	20	information	information	NN
cord-321976-ao3bg8xi	31	21	.	.	.
cord-321976-ao3bg8xi	32	1	The	the	DT
cord-321976-ao3bg8xi	32	2	evaluation	evaluation	NN
cord-321976-ao3bg8xi	32	3	must	must	MD
cord-321976-ao3bg8xi	32	4	also	also	RB
cord-321976-ao3bg8xi	32	5	consider	consider	VB
cord-321976-ao3bg8xi	32	6	each	each	DT
cord-321976-ao3bg8xi	32	7	person	person	NN
cord-321976-ao3bg8xi	32	8	's	's	POS
cord-321976-ao3bg8xi	32	9	risk	risk	NN
cord-321976-ao3bg8xi	32	10	of	of	IN
cord-321976-ao3bg8xi	32	11	exposure	exposure	NN
cord-321976-ao3bg8xi	32	12	and	and	CC
cord-321976-ao3bg8xi	32	13	infection	infection	NN
cord-321976-ao3bg8xi	32	14	,	,	,
cord-321976-ao3bg8xi	32	15	public	public	JJ
cord-321976-ao3bg8xi	32	16	health	health	NN
cord-321976-ao3bg8xi	32	17	measures	measure	NNS
cord-321976-ao3bg8xi	32	18	and	and	CC
cord-321976-ao3bg8xi	32	19	a	a	DT
cord-321976-ao3bg8xi	32	20	range	range	NN
cord-321976-ao3bg8xi	32	21	of	of	IN
cord-321976-ao3bg8xi	32	22	risk	risk	NN
cord-321976-ao3bg8xi	32	23	factors	factor	NNS
cord-321976-ao3bg8xi	32	24	.	.	.
cord-321976-ao3bg8xi	33	1	When	when	WRB
cord-321976-ao3bg8xi	33	2	coronavirus	coronavirus	NN
cord-321976-ao3bg8xi	33	3	disease	disease	NN
cord-321976-ao3bg8xi	33	4	(	(	-LRB-
cord-321976-ao3bg8xi	33	5	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	33	6	)	)	-RRB-
cord-321976-ao3bg8xi	33	7	emerged	emerge	VBD
cord-321976-ao3bg8xi	33	8	,	,	,
cord-321976-ao3bg8xi	33	9	there	there	EX
cord-321976-ao3bg8xi	33	10	was	be	VBD
cord-321976-ao3bg8xi	33	11	concern	concern	NN
cord-321976-ao3bg8xi	33	12	regarding	regard	VBG
cord-321976-ao3bg8xi	33	13	the	the	DT
cord-321976-ao3bg8xi	33	14	potential	potential	NN
cord-321976-ao3bg8xi	33	15	for	for	IN
cord-321976-ao3bg8xi	33	16	poor	poor	JJ
cord-321976-ao3bg8xi	33	17	outcomes	outcome	NNS
cord-321976-ao3bg8xi	33	18	in	in	IN
cord-321976-ao3bg8xi	33	19	patients	patient	NNS
cord-321976-ao3bg8xi	33	20	taking	take	VBG
cord-321976-ao3bg8xi	33	21	immunosuppressive	immunosuppressive	JJ
cord-321976-ao3bg8xi	33	22	drugs	drug	NNS
cord-321976-ao3bg8xi	33	23	for	for	IN
cord-321976-ao3bg8xi	33	24	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	33	25	diseases	disease	NNS
cord-321976-ao3bg8xi	33	26	.	.	.
cord-321976-ao3bg8xi	34	1	As	as	IN
cord-321976-ao3bg8xi	34	2	the	the	DT
cord-321976-ao3bg8xi	34	3	pandemic	pandemic	NN
cord-321976-ao3bg8xi	34	4	has	have	VBZ
cord-321976-ao3bg8xi	34	5	evolved	evolve	VBN
cord-321976-ao3bg8xi	34	6	,	,	,
cord-321976-ao3bg8xi	34	7	reports	report	NNS
cord-321976-ao3bg8xi	34	8	have	have	VBP
cord-321976-ao3bg8xi	34	9	added	add	VBN
cord-321976-ao3bg8xi	34	10	to	to	IN
cord-321976-ao3bg8xi	34	11	our	-PRON-	PRP$
cord-321976-ao3bg8xi	34	12	understanding	understanding	NN
cord-321976-ao3bg8xi	34	13	of	of	IN
cord-321976-ao3bg8xi	34	14	the	the	DT
cord-321976-ao3bg8xi	34	15	outcomes	outcome	NNS
cord-321976-ao3bg8xi	34	16	for	for	IN
cord-321976-ao3bg8xi	34	17	patients	patient	NNS
cord-321976-ao3bg8xi	34	18	who	who	WP
cord-321976-ao3bg8xi	34	19	are	be	VBP
cord-321976-ao3bg8xi	34	20	already	already	RB
cord-321976-ao3bg8xi	34	21	taking	take	VBG
cord-321976-ao3bg8xi	34	22	immunosuppressant	immunosuppressant	JJ
cord-321976-ao3bg8xi	34	23	drugs	drug	NNS
cord-321976-ao3bg8xi	34	24	.	.	.
cord-321976-ao3bg8xi	35	1	However	however	RB
cord-321976-ao3bg8xi	35	2	,	,	,
cord-321976-ao3bg8xi	35	3	these	these	DT
cord-321976-ao3bg8xi	35	4	studies	study	NNS
cord-321976-ao3bg8xi	35	5	have	have	VBP
cord-321976-ao3bg8xi	35	6	limitations	limitation	NNS
cord-321976-ao3bg8xi	35	7	which	which	WDT
cord-321976-ao3bg8xi	35	8	need	need	VBP
cord-321976-ao3bg8xi	35	9	to	to	TO
cord-321976-ao3bg8xi	35	10	be	be	VB
cord-321976-ao3bg8xi	35	11	considered	consider	VBN
cord-321976-ao3bg8xi	35	12	when	when	WRB
cord-321976-ao3bg8xi	35	13	making	make	VBG
cord-321976-ao3bg8xi	35	14	recommendations	recommendation	NNS
cord-321976-ao3bg8xi	35	15	based	base	VBN
cord-321976-ao3bg8xi	35	16	on	on	IN
cord-321976-ao3bg8xi	35	17	this	this	DT
cord-321976-ao3bg8xi	35	18	information	information	NN
cord-321976-ao3bg8xi	35	19	.	.	.
cord-321976-ao3bg8xi	36	1	In	in	IN
cord-321976-ao3bg8xi	36	2	discussions	discussion	NNS
cord-321976-ao3bg8xi	36	3	about	about	IN
cord-321976-ao3bg8xi	36	4	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	36	5	with	with	IN
cord-321976-ao3bg8xi	36	6	patients	patient	NNS
cord-321976-ao3bg8xi	36	7	taking	take	VBG
cord-321976-ao3bg8xi	36	8	immunosuppressants	immunosuppressant	NNS
cord-321976-ao3bg8xi	36	9	,	,	,
cord-321976-ao3bg8xi	36	10	the	the	DT
cord-321976-ao3bg8xi	36	11	first	first	JJ
cord-321976-ao3bg8xi	36	12	consideration	consideration	NN
cord-321976-ao3bg8xi	36	13	is	be	VBZ
cord-321976-ao3bg8xi	36	14	their	-PRON-	PRP$
cord-321976-ao3bg8xi	36	15	risk	risk	NN
cord-321976-ao3bg8xi	36	16	of	of	IN
cord-321976-ao3bg8xi	36	17	being	be	VBG
cord-321976-ao3bg8xi	36	18	infected	infect	VBN
cord-321976-ao3bg8xi	36	19	.	.	.
cord-321976-ao3bg8xi	37	1	This	this	DT
cord-321976-ao3bg8xi	37	2	depends	depend	VBZ
cord-321976-ao3bg8xi	37	3	on	on	IN
cord-321976-ao3bg8xi	37	4	local	local	JJ
cord-321976-ao3bg8xi	37	5	epidemiological	epidemiological	JJ
cord-321976-ao3bg8xi	37	6	factors	factor	NNS
cord-321976-ao3bg8xi	37	7	such	such	JJ
cord-321976-ao3bg8xi	37	8	as	as	IN
cord-321976-ao3bg8xi	37	9	the	the	DT
cord-321976-ao3bg8xi	37	10	numbers	number	NNS
cord-321976-ao3bg8xi	37	11	of	of	IN
cord-321976-ao3bg8xi	37	12	active	active	JJ
cord-321976-ao3bg8xi	37	13	cases	case	NNS
cord-321976-ao3bg8xi	37	14	and	and	CC
cord-321976-ao3bg8xi	37	15	the	the	DT
cord-321976-ao3bg8xi	37	16	level	level	NN
cord-321976-ao3bg8xi	37	17	of	of	IN
cord-321976-ao3bg8xi	37	18	community	community	NN
cord-321976-ao3bg8xi	37	19	transmission	transmission	NN
cord-321976-ao3bg8xi	37	20	.	.	.
cord-321976-ao3bg8xi	38	1	For	for	IN
cord-321976-ao3bg8xi	38	2	example	example	NN
cord-321976-ao3bg8xi	38	3	,	,	,
cord-321976-ao3bg8xi	38	4	the	the	DT
cord-321976-ao3bg8xi	38	5	risk	risk	NN
cord-321976-ao3bg8xi	38	6	of	of	IN
cord-321976-ao3bg8xi	38	7	infection	infection	NN
cord-321976-ao3bg8xi	38	8	will	will	MD
cord-321976-ao3bg8xi	38	9	be	be	VB
cord-321976-ao3bg8xi	38	10	much	much	RB
cord-321976-ao3bg8xi	38	11	higher	high	JJR
cord-321976-ao3bg8xi	38	12	for	for	IN
cord-321976-ao3bg8xi	38	13	a	a	DT
cord-321976-ao3bg8xi	38	14	patient	patient	NN
cord-321976-ao3bg8xi	38	15	living	live	VBG
cord-321976-ao3bg8xi	38	16	in	in	IN
cord-321976-ao3bg8xi	38	17	a	a	DT
cord-321976-ao3bg8xi	38	18	community	community	NN
cord-321976-ao3bg8xi	38	19	with	with	IN
cord-321976-ao3bg8xi	38	20	high	high	JJ
cord-321976-ao3bg8xi	38	21	levels	level	NNS
cord-321976-ao3bg8xi	38	22	of	of	IN
cord-321976-ao3bg8xi	38	23	transmission	transmission	NN
cord-321976-ao3bg8xi	38	24	compared	compare	VBN
cord-321976-ao3bg8xi	38	25	to	to	IN
cord-321976-ao3bg8xi	38	26	a	a	DT
cord-321976-ao3bg8xi	38	27	patient	patient	NN
cord-321976-ao3bg8xi	38	28	working	work	VBG
cord-321976-ao3bg8xi	38	29	exclusively	exclusively	RB
cord-321976-ao3bg8xi	38	30	at	at	IN
cord-321976-ao3bg8xi	38	31	home	home	NN
cord-321976-ao3bg8xi	38	32	in	in	IN
cord-321976-ao3bg8xi	38	33	an	an	DT
cord-321976-ao3bg8xi	38	34	area	area	NN
cord-321976-ao3bg8xi	38	35	with	with	IN
cord-321976-ao3bg8xi	38	36	a	a	DT
cord-321976-ao3bg8xi	38	37	low	low	JJ
cord-321976-ao3bg8xi	38	38	prevalence	prevalence	NN
cord-321976-ao3bg8xi	38	39	.	.	.
cord-321976-ao3bg8xi	39	1	These	these	DT
cord-321976-ao3bg8xi	39	2	risks	risk	NNS
cord-321976-ao3bg8xi	39	3	will	will	MD
cord-321976-ao3bg8xi	39	4	vary	vary	VB
cord-321976-ao3bg8xi	39	5	throughout	throughout	IN
cord-321976-ao3bg8xi	39	6	the	the	DT
cord-321976-ao3bg8xi	39	7	pandemic	pandemic	NN
cord-321976-ao3bg8xi	39	8	,	,	,
cord-321976-ao3bg8xi	39	9	influenced	influence	VBN
cord-321976-ao3bg8xi	39	10	by	by	IN
cord-321976-ao3bg8xi	39	11	public	public	JJ
cord-321976-ao3bg8xi	39	12	health	health	NN
cord-321976-ao3bg8xi	39	13	measures	measure	NNS
cord-321976-ao3bg8xi	39	14	such	such	JJ
cord-321976-ao3bg8xi	39	15	as	as	IN
cord-321976-ao3bg8xi	39	16	case	case	NN
cord-321976-ao3bg8xi	39	17	finding	finding	NN
cord-321976-ao3bg8xi	39	18	and	and	CC
cord-321976-ao3bg8xi	39	19	isolation	isolation	NN
cord-321976-ao3bg8xi	39	20	,	,	,
cord-321976-ao3bg8xi	39	21	physical	physical	JJ
cord-321976-ao3bg8xi	39	22	distancing	distancing	NN
cord-321976-ao3bg8xi	39	23	and	and	CC
cord-321976-ao3bg8xi	39	24	hand	hand	NN
cord-321976-ao3bg8xi	39	25	hygiene	hygiene	NN
cord-321976-ao3bg8xi	39	26	.	.	.
cord-321976-ao3bg8xi	40	1	If	if	IN
cord-321976-ao3bg8xi	40	2	a	a	DT
cord-321976-ao3bg8xi	40	3	patient	patient	NN
cord-321976-ao3bg8xi	40	4	is	be	VBZ
cord-321976-ao3bg8xi	40	5	infected	infect	VBN
cord-321976-ao3bg8xi	40	6	,	,	,
cord-321976-ao3bg8xi	40	7	the	the	DT
cord-321976-ao3bg8xi	40	8	risk	risk	NN
cord-321976-ao3bg8xi	40	9	of	of	IN
cord-321976-ao3bg8xi	40	10	an	an	DT
cord-321976-ao3bg8xi	40	11	adverse	adverse	JJ
cord-321976-ao3bg8xi	40	12	outcome	outcome	NN
cord-321976-ao3bg8xi	40	13	depends	depend	VBZ
cord-321976-ao3bg8xi	40	14	on	on	IN
cord-321976-ao3bg8xi	40	15	modifiable	modifiable	JJ
cord-321976-ao3bg8xi	40	16	and	and	CC
cord-321976-ao3bg8xi	40	17	non	non	JJ
cord-321976-ao3bg8xi	40	18	-	-	JJ
cord-321976-ao3bg8xi	40	19	modifiable	modifiable	JJ
cord-321976-ao3bg8xi	40	20	factors	factor	NNS
cord-321976-ao3bg8xi	40	21	.	.	.
cord-321976-ao3bg8xi	41	1	Non	non	JJ
cord-321976-ao3bg8xi	41	2	-	-	JJ
cord-321976-ao3bg8xi	41	3	modifiable	modifiable	JJ
cord-321976-ao3bg8xi	41	4	risk	risk	NN
cord-321976-ao3bg8xi	41	5	factors	factor	NNS
cord-321976-ao3bg8xi	41	6	include	include	VBP
cord-321976-ao3bg8xi	41	7	older	old	JJR
cord-321976-ao3bg8xi	41	8	age	age	NN
cord-321976-ao3bg8xi	41	9	and	and	CC
cord-321976-ao3bg8xi	41	10	comorbidities	comorbiditie	NNS
cord-321976-ao3bg8xi	41	11	.	.	.
cord-321976-ao3bg8xi	42	1	Initial	initial	JJ
cord-321976-ao3bg8xi	42	2	data	datum	NNS
cord-321976-ao3bg8xi	42	3	from	from	IN
cord-321976-ao3bg8xi	42	4	600	600	CD
cord-321976-ao3bg8xi	42	5	patients	patient	NNS
cord-321976-ao3bg8xi	42	6	with	with	IN
cord-321976-ao3bg8xi	42	7	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	42	8	diseases	disease	NNS
cord-321976-ao3bg8xi	42	9	who	who	WP
cord-321976-ao3bg8xi	42	10	were	be	VBD
cord-321976-ao3bg8xi	42	11	infected	infect	VBN
cord-321976-ao3bg8xi	42	12	do	do	VBP
cord-321976-ao3bg8xi	42	13	not	not	RB
cord-321976-ao3bg8xi	42	14	show	show	VB
cord-321976-ao3bg8xi	42	15	any	any	DT
cord-321976-ao3bg8xi	42	16	difference	difference	NN
cord-321976-ao3bg8xi	42	17	in	in	IN
cord-321976-ao3bg8xi	42	18	the	the	DT
cord-321976-ao3bg8xi	42	19	risk	risk	NN
cord-321976-ao3bg8xi	42	20	of	of	IN
cord-321976-ao3bg8xi	42	21	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	42	22	for	for	IN
cord-321976-ao3bg8xi	42	23	COVID-19	covid-19	NN
cord-321976-ao3bg8xi	42	24	between	between	IN
cord-321976-ao3bg8xi	42	25	patients	patient	NNS
cord-321976-ao3bg8xi	42	26	with	with	IN
cord-321976-ao3bg8xi	42	27	rheumatoid	rheumatoid	NN
cord-321976-ao3bg8xi	42	28	arthritis	arthritis	NN
cord-321976-ao3bg8xi	42	29	,	,	,
cord-321976-ao3bg8xi	42	30	and	and	CC
cord-321976-ao3bg8xi	42	31	patients	patient	NNS
cord-321976-ao3bg8xi	42	32	with	with	IN
cord-321976-ao3bg8xi	42	33	systemic	systemic	JJ
cord-321976-ao3bg8xi	42	34	lupus	lupus	NN
cord-321976-ao3bg8xi	42	35	erythematosus	erythematosus	NN
cord-321976-ao3bg8xi	42	36	,	,	,
cord-321976-ao3bg8xi	42	37	psoriatic	psoriatic	JJ
cord-321976-ao3bg8xi	42	38	arthritis	arthritis	NN
cord-321976-ao3bg8xi	42	39	,	,	,
cord-321976-ao3bg8xi	42	40	axial	axial	JJ
cord-321976-ao3bg8xi	42	41	spondyloarthritis	spondyloarthritis	NN
cord-321976-ao3bg8xi	42	42	or	or	CC
cord-321976-ao3bg8xi	42	43	vasculitis	vasculitis	NN
cord-321976-ao3bg8xi	42	44	.	.	.
cord-321976-ao3bg8xi	43	1	1	1	LS
cord-321976-ao3bg8xi	44	1	Another	another	DT
cord-321976-ao3bg8xi	44	2	series	series	NN
cord-321976-ao3bg8xi	44	3	of	of	IN
cord-321976-ao3bg8xi	44	4	86	86	CD
cord-321976-ao3bg8xi	44	5	patients	patient	NNS
cord-321976-ao3bg8xi	44	6	from	from	IN
cord-321976-ao3bg8xi	44	7	New	New	NNP
cord-321976-ao3bg8xi	44	8	York	York	NNP
cord-321976-ao3bg8xi	44	9	found	find	VBD
cord-321976-ao3bg8xi	44	10	no	no	DT
cord-321976-ao3bg8xi	44	11	increase	increase	NN
cord-321976-ao3bg8xi	44	12	in	in	IN
cord-321976-ao3bg8xi	44	13	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	44	14	for	for	IN
cord-321976-ao3bg8xi	44	15	patients	patient	NNS
cord-321976-ao3bg8xi	44	16	with	with	IN
cord-321976-ao3bg8xi	44	17	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	44	18	disease	disease	NN
cord-321976-ao3bg8xi	44	19	compared	compare	VBN
cord-321976-ao3bg8xi	44	20	to	to	IN
cord-321976-ao3bg8xi	44	21	the	the	DT
cord-321976-ao3bg8xi	44	22	background	background	NN
cord-321976-ao3bg8xi	44	23	rate	rate	NN
cord-321976-ao3bg8xi	44	24	in	in	IN
cord-321976-ao3bg8xi	44	25	the	the	DT
cord-321976-ao3bg8xi	44	26	community	community	NN
cord-321976-ao3bg8xi	44	27	.	.	.
cord-321976-ao3bg8xi	45	1	The	the	DT
cord-321976-ao3bg8xi	45	2	mortality	mortality	NN
cord-321976-ao3bg8xi	45	3	rate	rate	NN
cord-321976-ao3bg8xi	45	4	was	be	VBD
cord-321976-ao3bg8xi	45	5	1	1	CD
cord-321976-ao3bg8xi	45	6	%	%	NN
cord-321976-ao3bg8xi	45	7	,	,	,
cord-321976-ao3bg8xi	45	8	which	which	WDT
cord-321976-ao3bg8xi	45	9	was	be	VBD
cord-321976-ao3bg8xi	45	10	consistent	consistent	JJ
cord-321976-ao3bg8xi	45	11	with	with	IN
cord-321976-ao3bg8xi	45	12	general	general	JJ
cord-321976-ao3bg8xi	45	13	cohorts	cohort	NNS
cord-321976-ao3bg8xi	45	14	of	of	IN
cord-321976-ao3bg8xi	45	15	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	45	16	patients	patient	NNS
cord-321976-ao3bg8xi	45	17	.	.	.
cord-321976-ao3bg8xi	46	1	2	2	LS
cord-321976-ao3bg8xi	46	2	Full	full	JJ
cord-321976-ao3bg8xi	46	3	text	text	NN
cord-321976-ao3bg8xi	46	4	free	free	JJ
cord-321976-ao3bg8xi	46	5	online	online	RB
cord-321976-ao3bg8xi	46	6	at	at	IN
cord-321976-ao3bg8xi	46	7	nps.org.au/australian-prescriber	nps.org.au/australian-prescriber	NNP
cord-321976-ao3bg8xi	46	8	VOLUME	volume	NN
cord-321976-ao3bg8xi	46	9	43	43	CD
cord-321976-ao3bg8xi	47	1	:	:	:
cord-321976-ao3bg8xi	47	2	NUMBER	number	NN
cord-321976-ao3bg8xi	47	3	5	5	CD
cord-321976-ao3bg8xi	47	4	:	:	:
cord-321976-ao3bg8xi	47	5	OCTOBER	OCTOBER	NNP
cord-321976-ao3bg8xi	47	6	2020	2020	CD
cord-321976-ao3bg8xi	47	7	of	of	IN
cord-321976-ao3bg8xi	47	8	confirmed	confirm	VBN
cord-321976-ao3bg8xi	47	9	or	or	CC
cord-321976-ao3bg8xi	47	10	suspected	suspect	VBN
cord-321976-ao3bg8xi	47	11	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	47	12	,	,	,
cord-321976-ao3bg8xi	47	13	treatment	treatment	NN
cord-321976-ao3bg8xi	47	14	for	for	IN
cord-321976-ao3bg8xi	47	15	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	47	16	disease	disease	NN
cord-321976-ao3bg8xi	47	17	should	should	MD
cord-321976-ao3bg8xi	47	18	not	not	RB
cord-321976-ao3bg8xi	47	19	be	be	VB
cord-321976-ao3bg8xi	47	20	altered	alter	VBN
cord-321976-ao3bg8xi	47	21	.	.	.
cord-321976-ao3bg8xi	48	1	5	5	CD
cord-321976-ao3bg8xi	48	2	,	,	,
cord-321976-ao3bg8xi	48	3	6	6	CD
cord-321976-ao3bg8xi	48	4	If	if	IN
cord-321976-ao3bg8xi	48	5	SARS	SARS	NNP
cord-321976-ao3bg8xi	48	6	-	-	HYPH
cord-321976-ao3bg8xi	48	7	CoV-2	CoV-2	NNP
cord-321976-ao3bg8xi	48	8	infection	infection	NN
cord-321976-ao3bg8xi	48	9	is	be	VBZ
cord-321976-ao3bg8xi	48	10	confirmed	confirm	VBN
cord-321976-ao3bg8xi	48	11	,	,	,
cord-321976-ao3bg8xi	48	12	ACR	ACR	NNP
cord-321976-ao3bg8xi	48	13	guidelines	guideline	NNS
cord-321976-ao3bg8xi	48	14	suggest	suggest	VBP
cord-321976-ao3bg8xi	48	15	suspending	suspend	VBG
cord-321976-ao3bg8xi	48	16	immunosuppression	immunosuppression	NN
cord-321976-ao3bg8xi	48	17	,	,	,
cord-321976-ao3bg8xi	48	18	however	however	RB
cord-321976-ao3bg8xi	48	19	they	-PRON-	PRP
cord-321976-ao3bg8xi	48	20	do	do	VBP
cord-321976-ao3bg8xi	48	21	state	state	VB
cord-321976-ao3bg8xi	48	22	that	that	IN
cord-321976-ao3bg8xi	48	23	as	as	IN
cord-321976-ao3bg8xi	48	24	part	part	NN
cord-321976-ao3bg8xi	48	25	of	of	IN
cord-321976-ao3bg8xi	48	26	a	a	DT
cord-321976-ao3bg8xi	48	27	shared	share	VBN
cord-321976-ao3bg8xi	48	28	decision	decision	NN
cord-321976-ao3bg8xi	48	29	-	-	HYPH
cord-321976-ao3bg8xi	48	30	making	making	NN
cord-321976-ao3bg8xi	48	31	process	process	NN
cord-321976-ao3bg8xi	49	1	interleukin-6	interleukin-6	NNP
cord-321976-ao3bg8xi	49	2	inhibitors	inhibitor	NNS
cord-321976-ao3bg8xi	49	3	may	may	MD
cord-321976-ao3bg8xi	49	4	be	be	VB
cord-321976-ao3bg8xi	49	5	continued	continue	VBN
cord-321976-ao3bg8xi	49	6	.	.	.
cord-321976-ao3bg8xi	50	1	The	the	DT
cord-321976-ao3bg8xi	50	2	potential	potential	NN
cord-321976-ao3bg8xi	50	3	to	to	TO
cord-321976-ao3bg8xi	50	4	continue	continue	VB
cord-321976-ao3bg8xi	50	5	therapy	therapy	NN
cord-321976-ao3bg8xi	50	6	may	may	MD
cord-321976-ao3bg8xi	50	7	be	be	VB
cord-321976-ao3bg8xi	50	8	extended	extend	VBN
cord-321976-ao3bg8xi	50	9	to	to	IN
cord-321976-ao3bg8xi	50	10	other	other	JJ
cord-321976-ao3bg8xi	50	11	immunosuppressants	immunosuppressant	NNS
cord-321976-ao3bg8xi	50	12	in	in	IN
cord-321976-ao3bg8xi	50	13	later	later	JJ
cord-321976-ao3bg8xi	50	14	versions	version	NNS
cord-321976-ao3bg8xi	50	15	of	of	IN
cord-321976-ao3bg8xi	50	16	the	the	DT
cord-321976-ao3bg8xi	50	17	guidelines	guideline	NNS
cord-321976-ao3bg8xi	50	18	.	.	.
cord-321976-ao3bg8xi	51	1	As	as	IN
cord-321976-ao3bg8xi	51	2	we	-PRON-	PRP
cord-321976-ao3bg8xi	51	3	learn	learn	VBP
cord-321976-ao3bg8xi	51	4	more	more	RBR
cord-321976-ao3bg8xi	51	5	about	about	IN
cord-321976-ao3bg8xi	51	6	immunosuppressed	immunosuppressed	JJ
cord-321976-ao3bg8xi	51	7	patients	patient	NNS
cord-321976-ao3bg8xi	51	8	and	and	CC
cord-321976-ao3bg8xi	51	9	their	-PRON-	PRP$
cord-321976-ao3bg8xi	51	10	response	response	NN
cord-321976-ao3bg8xi	51	11	to	to	TO
cord-321976-ao3bg8xi	51	12	COVID-19	covid-19	VB
cord-321976-ao3bg8xi	51	13	our	-PRON-	PRP$
cord-321976-ao3bg8xi	51	14	approach	approach	NN
cord-321976-ao3bg8xi	51	15	will	will	MD
cord-321976-ao3bg8xi	51	16	undoubtably	undoubtably	RB
cord-321976-ao3bg8xi	51	17	be	be	VB
cord-321976-ao3bg8xi	51	18	refined	refine	VBN
cord-321976-ao3bg8xi	51	19	.	.	.
cord-321976-ao3bg8xi	52	1	For	for	IN
cord-321976-ao3bg8xi	52	2	now	now	RB
cord-321976-ao3bg8xi	52	3	,	,	,
cord-321976-ao3bg8xi	52	4	we	-PRON-	PRP
cord-321976-ao3bg8xi	52	5	need	need	VBP
cord-321976-ao3bg8xi	52	6	to	to	TO
cord-321976-ao3bg8xi	52	7	recognise	recognise	VB
cord-321976-ao3bg8xi	52	8	that	that	IN
cord-321976-ao3bg8xi	52	9	there	there	EX
cord-321976-ao3bg8xi	52	10	is	be	VBZ
cord-321976-ao3bg8xi	52	11	no	no	DT
cord-321976-ao3bg8xi	52	12	right	right	JJ
cord-321976-ao3bg8xi	52	13	answer	answer	NN
cord-321976-ao3bg8xi	52	14	-the	-the	ADD
cord-321976-ao3bg8xi	52	15	limited	limited	JJ
cord-321976-ao3bg8xi	52	16	information	information	NN
cord-321976-ao3bg8xi	52	17	we	-PRON-	PRP
cord-321976-ao3bg8xi	52	18	have	have	VBP
cord-321976-ao3bg8xi	52	19	must	must	MD
cord-321976-ao3bg8xi	52	20	be	be	VB
cord-321976-ao3bg8xi	52	21	tailored	tailor	VBN
cord-321976-ao3bg8xi	52	22	to	to	IN
cord-321976-ao3bg8xi	52	23	each	each	DT
cord-321976-ao3bg8xi	52	24	patient	patient	NN
cord-321976-ao3bg8xi	52	25	.	.	.
cord-321976-ao3bg8xi	53	1	Philip	Philip	NNP
cord-321976-ao3bg8xi	53	2	Robinson	Robinson	NNP
cord-321976-ao3bg8xi	53	3	reports	report	VBZ
cord-321976-ao3bg8xi	53	4	personal	personal	JJ
cord-321976-ao3bg8xi	53	5	fees	fee	NNS
cord-321976-ao3bg8xi	53	6	from	from	IN
cord-321976-ao3bg8xi	53	7	Abbvie	Abbvie	NNP
cord-321976-ao3bg8xi	53	8	,	,	,
cord-321976-ao3bg8xi	53	9	Eli	Eli	NNP
cord-321976-ao3bg8xi	53	10	Lilly	Lilly	NNP
cord-321976-ao3bg8xi	53	11	,	,	,
cord-321976-ao3bg8xi	53	12	Gilead	Gilead	NNP
cord-321976-ao3bg8xi	53	13	,	,	,
cord-321976-ao3bg8xi	53	14	Janssen	Janssen	NNP
cord-321976-ao3bg8xi	53	15	,	,	,
cord-321976-ao3bg8xi	53	16	Novartis	Novartis	NNP
cord-321976-ao3bg8xi	53	17	,	,	,
cord-321976-ao3bg8xi	53	18	UCB	UCB	NNP
cord-321976-ao3bg8xi	53	19	Pharma	Pharma	NNP
cord-321976-ao3bg8xi	53	20	,	,	,
cord-321976-ao3bg8xi	53	21	Roche	Roche	NNP
cord-321976-ao3bg8xi	53	22	,	,	,
cord-321976-ao3bg8xi	53	23	Pfizer	Pfizer	NNP
cord-321976-ao3bg8xi	53	24	,	,	,
cord-321976-ao3bg8xi	53	25	and	and	CC
cord-321976-ao3bg8xi	53	26	non	non	JJ
cord-321976-ao3bg8xi	53	27	-	-	JJ
cord-321976-ao3bg8xi	53	28	financial	financial	JJ
cord-321976-ao3bg8xi	53	29	support	support	NN
cord-321976-ao3bg8xi	53	30	from	from	IN
cord-321976-ao3bg8xi	53	31	Roche	Roche	NNP
cord-321976-ao3bg8xi	53	32	and	and	CC
cord-321976-ao3bg8xi	53	33	BMS	BMS	NNP
cord-321976-ao3bg8xi	53	34	,	,	,
cord-321976-ao3bg8xi	53	35	and	and	CC
cord-321976-ao3bg8xi	53	36	research	research	NN
cord-321976-ao3bg8xi	53	37	grant	grant	NN
cord-321976-ao3bg8xi	53	38	funding	funding	NN
cord-321976-ao3bg8xi	53	39	from	from	IN
cord-321976-ao3bg8xi	53	40	Janssen	Janssen	NNP
cord-321976-ao3bg8xi	53	41	,	,	,
cord-321976-ao3bg8xi	53	42	UCB	UCB	NNP
cord-321976-ao3bg8xi	53	43	Pharma	Pharma	NNP
cord-321976-ao3bg8xi	53	44	and	and	CC
cord-321976-ao3bg8xi	53	45	Novartis	Novartis	NNP
cord-321976-ao3bg8xi	53	46	.	.	.
cord-321976-ao3bg8xi	54	1	He	-PRON-	PRP
cord-321976-ao3bg8xi	54	2	is	be	VBZ
cord-321976-ao3bg8xi	54	3	the	the	DT
cord-321976-ao3bg8xi	54	4	chair	chair	NN
cord-321976-ao3bg8xi	54	5	of	of	IN
cord-321976-ao3bg8xi	54	6	the	the	DT
cord-321976-ao3bg8xi	54	7	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	54	8	Global	Global	NNP
cord-321976-ao3bg8xi	54	9	Rheumatology	Rheumatology	NNP
cord-321976-ao3bg8xi	54	10	Alliance	Alliance	NNP
cord-321976-ao3bg8xi	54	11	steering	steering	NN
cord-321976-ao3bg8xi	54	12	committee	committee	NN
cord-321976-ao3bg8xi	54	13	which	which	WDT
cord-321976-ao3bg8xi	54	14	has	have	VBZ
cord-321976-ao3bg8xi	54	15	funding	funding	NN
cord-321976-ao3bg8xi	54	16	from	from	IN
cord-321976-ao3bg8xi	54	17	Amgen	Amgen	NNP
cord-321976-ao3bg8xi	54	18	and	and	CC
cord-321976-ao3bg8xi	54	19	Janssen	Janssen	NNP
cord-321976-ao3bg8xi	54	20	.	.	.
cord-321976-ao3bg8xi	55	1	Evan	Evan	NNP
cord-321976-ao3bg8xi	55	2	Bursle	Bursle	NNP
cord-321976-ao3bg8xi	55	3	has	have	VBZ
cord-321976-ao3bg8xi	55	4	received	receive	VBN
cord-321976-ao3bg8xi	55	5	speaker	speaker	NN
cord-321976-ao3bg8xi	55	6	fees	fee	NNS
cord-321976-ao3bg8xi	55	7	from	from	IN
cord-321976-ao3bg8xi	55	8	Gilead	Gilead	NNP
cord-321976-ao3bg8xi	55	9	,	,	,
cord-321976-ao3bg8xi	55	10	Novartis	Novartis	NNP
cord-321976-ao3bg8xi	55	11	and	and	CC
cord-321976-ao3bg8xi	55	12	Pfizer	Pfizer	NNP
cord-321976-ao3bg8xi	55	13	.	.	.
cord-321976-ao3bg8xi	56	1	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	56	2	Global	Global	NNP
cord-321976-ao3bg8xi	56	3	Rheumatology	Rheumatology	NNP
cord-321976-ao3bg8xi	56	4	Alliance	Alliance	NNP
cord-321976-ao3bg8xi	56	5	.	.	.
cord-321976-ao3bg8xi	57	1	Characteristics	characteristic	NNS
cord-321976-ao3bg8xi	57	2	associated	associate	VBN
cord-321976-ao3bg8xi	57	3	with	with	IN
cord-321976-ao3bg8xi	57	4	hospitalisation	hospitalisation	NN
cord-321976-ao3bg8xi	57	5	for	for	IN
cord-321976-ao3bg8xi	57	6	COVID-19	covid-19	NN
cord-321976-ao3bg8xi	57	7	in	in	IN
cord-321976-ao3bg8xi	57	8	people	people	NNS
cord-321976-ao3bg8xi	57	9	with	with	IN
cord-321976-ao3bg8xi	57	10	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	57	11	disease	disease	NN
cord-321976-ao3bg8xi	57	12	:	:	:
cord-321976-ao3bg8xi	57	13	data	datum	NNS
cord-321976-ao3bg8xi	57	14	from	from	IN
cord-321976-ao3bg8xi	57	15	the	the	DT
cord-321976-ao3bg8xi	57	16	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	57	17	Global	Global	NNP
cord-321976-ao3bg8xi	57	18	Rheumatology	Rheumatology	NNP
cord-321976-ao3bg8xi	57	19	Alliance	Alliance	NNP
cord-321976-ao3bg8xi	57	20	physician	physician	NN
cord-321976-ao3bg8xi	57	21	-	-	HYPH
cord-321976-ao3bg8xi	57	22	reported	report	VBN
cord-321976-ao3bg8xi	57	23	registry	registry	NN
cord-321976-ao3bg8xi	57	24	Covid-19	covid-19	NN
cord-321976-ao3bg8xi	57	25	in	in	IN
cord-321976-ao3bg8xi	57	26	immune	immune	NN
cord-321976-ao3bg8xi	57	27	-	-	HYPH
cord-321976-ao3bg8xi	57	28	mediated	mediate	VBN
cord-321976-ao3bg8xi	57	29	inflammatory	inflammatory	JJ
cord-321976-ao3bg8xi	57	30	diseasescase	diseasescase	NN
cord-321976-ao3bg8xi	57	31	series	series	NN
cord-321976-ao3bg8xi	57	32	from	from	IN
cord-321976-ao3bg8xi	57	33	New	New	NNP
cord-321976-ao3bg8xi	57	34	York	York	NNP
cord-321976-ao3bg8xi	57	35	Clinical	clinical	JJ
cord-321976-ao3bg8xi	57	36	characteristics	characteristic	NNS
cord-321976-ao3bg8xi	57	37	and	and	CC
cord-321976-ao3bg8xi	57	38	outcomes	outcome	NNS
cord-321976-ao3bg8xi	57	39	of	of	IN
cord-321976-ao3bg8xi	57	40	patients	patient	NNS
cord-321976-ao3bg8xi	57	41	with	with	IN
cord-321976-ao3bg8xi	57	42	coronavirus	coronavirus	NN
cord-321976-ao3bg8xi	57	43	disease	disease	NN
cord-321976-ao3bg8xi	57	44	2019	2019	CD
cord-321976-ao3bg8xi	57	45	(	(	-LRB-
cord-321976-ao3bg8xi	57	46	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	57	47	)	)	-RRB-
cord-321976-ao3bg8xi	57	48	and	and	CC
cord-321976-ao3bg8xi	57	49	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	57	50	disease	disease	NN
cord-321976-ao3bg8xi	57	51	:	:	:
cord-321976-ao3bg8xi	57	52	a	a	DT
cord-321976-ao3bg8xi	57	53	comparative	comparative	JJ
cord-321976-ao3bg8xi	57	54	cohort	cohort	NN
cord-321976-ao3bg8xi	57	55	study	study	NN
cord-321976-ao3bg8xi	57	56	from	from	IN
cord-321976-ao3bg8xi	57	57	a	a	DT
cord-321976-ao3bg8xi	57	58	US	US	NNP
cord-321976-ao3bg8xi	57	59	'	'	POS
cord-321976-ao3bg8xi	57	60	hot	hot	JJ
cord-321976-ao3bg8xi	57	61	spot	spot	NN
cord-321976-ao3bg8xi	57	62	but	but	CC
cord-321976-ao3bg8xi	57	63	not	not	RB
cord-321976-ao3bg8xi	57	64	TNF	TNF	NNP
cord-321976-ao3bg8xi	57	65	antagonists	antagonist	NNS
cord-321976-ao3bg8xi	57	66	,	,	,
cord-321976-ao3bg8xi	57	67	are	be	VBP
cord-321976-ao3bg8xi	57	68	associated	associate	VBN
cord-321976-ao3bg8xi	57	69	with	with	IN
cord-321976-ao3bg8xi	57	70	adverse	adverse	JJ
cord-321976-ao3bg8xi	57	71	COVID-19	covid-19	JJ
cord-321976-ao3bg8xi	57	72	outcomes	outcome	NNS
cord-321976-ao3bg8xi	57	73	in	in	IN
cord-321976-ao3bg8xi	57	74	patients	patient	NNS
cord-321976-ao3bg8xi	57	75	with	with	IN
cord-321976-ao3bg8xi	57	76	inflammatory	inflammatory	JJ
cord-321976-ao3bg8xi	57	77	bowel	bowel	NN
cord-321976-ao3bg8xi	57	78	diseases	disease	NNS
cord-321976-ao3bg8xi	57	79	:	:	:
cord-321976-ao3bg8xi	57	80	results	result	NNS
cord-321976-ao3bg8xi	57	81	from	from	IN
cord-321976-ao3bg8xi	57	82	an	an	DT
cord-321976-ao3bg8xi	57	83	international	international	JJ
cord-321976-ao3bg8xi	57	84	registry	registry	NN
cord-321976-ao3bg8xi	57	85	American	American	NNP
cord-321976-ao3bg8xi	57	86	College	College	NNP
cord-321976-ao3bg8xi	57	87	of	of	IN
cord-321976-ao3bg8xi	57	88	Rheumatology	Rheumatology	NNP
cord-321976-ao3bg8xi	57	89	guidance	guidance	NN
cord-321976-ao3bg8xi	57	90	for	for	IN
cord-321976-ao3bg8xi	57	91	the	the	DT
cord-321976-ao3bg8xi	57	92	management	management	NN
cord-321976-ao3bg8xi	57	93	of	of	IN
cord-321976-ao3bg8xi	57	94	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	57	95	disease	disease	NN
cord-321976-ao3bg8xi	57	96	in	in	IN
cord-321976-ao3bg8xi	57	97	adult	adult	NN
cord-321976-ao3bg8xi	57	98	patients	patient	NNS
cord-321976-ao3bg8xi	57	99	during	during	IN
cord-321976-ao3bg8xi	57	100	the	the	DT
cord-321976-ao3bg8xi	57	101	COVID-19	COVID-19	NNP
cord-321976-ao3bg8xi	57	102	pandemic	pandemic	NN
cord-321976-ao3bg8xi	57	103	:	:	:
cord-321976-ao3bg8xi	58	1	Version	version	NN
cord-321976-ao3bg8xi	58	2	1	1	CD
cord-321976-ao3bg8xi	58	3	EULAR	EULAR	NNP
cord-321976-ao3bg8xi	58	4	provisional	provisional	JJ
cord-321976-ao3bg8xi	58	5	recommendations	recommendation	NNS
cord-321976-ao3bg8xi	58	6	for	for	IN
cord-321976-ao3bg8xi	58	7	the	the	DT
cord-321976-ao3bg8xi	58	8	management	management	NN
cord-321976-ao3bg8xi	58	9	of	of	IN
cord-321976-ao3bg8xi	58	10	rheumatic	rheumatic	JJ
cord-321976-ao3bg8xi	58	11	and	and	CC
cord-321976-ao3bg8xi	58	12	musculoskeletal	musculoskeletal	JJ
cord-321976-ao3bg8xi	58	13	diseases	disease	NNS
cord-321976-ao3bg8xi	58	14	in	in	IN
cord-321976-ao3bg8xi	58	15	the	the	DT
cord-321976-ao3bg8xi	58	16	context	context	NN
cord-321976-ao3bg8xi	58	17	of	of	IN
cord-321976-ao3bg8xi	58	18	SARS	SARS	NNP
cord-321976-ao3bg8xi	58	19	-	-	HYPH
cord-321976-ao3bg8xi	58	20	CoV-2	CoV-2	NNP